November 12, 2024
As we continue to grapple with the results of the US presidential election and what this means for our work and for global health evidence- and rights-based policies and programs generally, we wanted to share a range of new tools and resources you may find helpful in your advocacy for choice, science and rights.
Injectable Lenacapavir for PrEP
Additional LEN Resources
- Report: From Clinical Trial Efficacy to Public Health Impact: A Plan for Accelerating Access to Injectable Lenacapavir for PrEP
- PxPulse Podcast Lenacapavir: The case for investing in delivering HIV prevention
- Advocates’ Guide: The Lens on LEN: The Basics on Injectable Lenacapavir as PrEP
- Graphic: An Overview of Lenacapavir for PrEP Trials
- Graphic: Moving a Product to the Real World
- Recording: Breaking New Ground: Expanding Access to Lenacapavir—Lessons from Dolutegravir and the Future of HIV Prevention
- Graphic: The Future of ARV-Based Prevention and More
- See our lenacapavir page for a full suite of resources
Webinars on the STI Pipeline, Advances in Research Ethics, and Money for the DVR and More!
In Case You Missed It
Recording / Slides / DVR Early Market Access Vehicle page
And stay tuned for a new PxPulse podcast featuring Jen Kates of KFF and AVAC’s Suraj Madoori, The Votes Are In: What’s next for the US’ role in global health and HIV prevention. The podcast hits airways November 14.